1.Predicted Factors of Remission in Graves' Disease.
Journal of Korean Society of Pediatric Endocrinology 2007;12(1):1-5
No abstract available.
Graves Disease*
2.Graves' Disease: Current and Future Directions.
Korean Journal of Endocrine Surgery 2001;1(1):1-5
No abstract available.
Graves Disease*
3.Guillain-Barré syndrome developing in a patient with Graves' disease.
Journal of the ASEAN Federation of Endocrine Societies 2019;34(1):103-106
Graves' disease (GD) and Guillain-Barre syndrome (GBS) are both autoimmune disorders and are triggered by interactions between genetic and environmental factors. GBS in patients who suffer from other autoimmune diseases is rarely reported, and the development of atypical GBS with cranial nerve involvement in a patient with GD has never been previously reported. Herein, we report a patient with GD and a rare form of pharyngo-cervico-brachial variety of GBS.
Graves Disease
4.Primary hypothyroidism following Graves' disease.
Min Ho SHONG ; Ka Hee YI ; Bo Youn CHO ; Hong Kyu LEE ; Chang Soon KOH ; Hun Ki MIN
Journal of Korean Society of Endocrinology 1991;6(1):68-74
No abstract available.
Graves Disease*
;
Hypothyroidism*
5.The variation of blood biochemical indices before and after treating Basedow’s disease using propyl thiouracyl
Journal of Practical Medicine 2004;480(5):19-21
After a 4 weeks of treatment by propyl thyouracil, the biochemical indices of Basedow disease had changed obviously: triiodothyronin (T3) high level (7.95 ± 1.58 nmol/l before treatment) had increased dramatically (1.98 ± 0.54 nmol/l), total thyroxin (T4) high level (257.56 ± 47.45 nmol/l before treatment) had decreased dramatically (1278.04 ± 10.82 nmol/l). FT4 serum level high level had decreased after treatment. TSF low level before treatment had increased. But after treatment glucose level had increased unsignificantly versus that before. In severe condition blood cholesterol had increased, but in moderate and mild condition, there was no change.
Blood
;
Therapeutics
;
Graves Disease
6.Current trends in the diagnosis and treatment of Graves' disease in Korea.
Journal of Korean Society of Endocrinology 1992;7(3):216-227
No abstract available.
Diagnosis*
;
Graves Disease*
;
Korea*
7.Genetics of Graves' Disease.
Journal of Korean Society of Endocrinology 2003;18(1):5-11
No abstract available.
Genetics*
;
Graves Disease*
8.Graves' disease complicating pregnancy.
Sung Soo KIM ; Bo Hyun YOON ; Bo Youn CHO ; Hee Chul SYN ; Syng Wook KIM
Korean Journal of Perinatology 1991;2(1):105-113
No abstract available.
Graves Disease*
;
Pregnancy*
9.A case report of insulin autoimmune syndrome in graves' disease.
Kyung Sang LEE ; Ji Hoon KIM ; Woong Hwan CHOI ; Tae Wha KIM ; Mok Hyun KIM
Journal of Korean Society of Endocrinology 1993;8(4):451-455
No abstract available.
Graves Disease*
;
Insulin*
10.Use of radioiodine (I-131) in the treatment of hyperthyroidism whether causes cancer and genetic mutation or not
Journal of Medical and Pharmaceutical Information 2000;8():10-14
For the past 60 years, there have been millions with hyperthyroidism and Basedow patients treated successfully by radioiodine (I-131). The number of patients with hyperthyroidism and Basedow treated by I-131 was the same as this received operations. The radioiodine therapy was a safe, effective and economic method with easy to implement that should be selected among methods of treatment of hyperthyroidism and Basedow
Hyperthyroidism
;
Graves Disease
;
Therapeutics
Result Analysis
Print
Save
E-mail